0.89 | 2.32%
0.89 | 2.32%
30d. avg volume.
39.01 - 40.50
27.88 - 41.99
News and Commentary
When Will U.S. Airlines Catch a Break? Airlines, one of the hardest hit industries within the travel and leisure sector, are beginning to see a slight uptake in domestic holiday travelers ahead of the U.S. Thanksgivin...
AstraZeneca, Oxford Vaccine Found to be up to 90% Effective, 70% on Average British pharmaceutical giant AstraZeneca (
Market Update: Stocks Gain on Brighter Vaccine and Economic Outlooks Stocks gained on Monday as sentiment was encouraged by new vaccine developments and Wall Street favored choices for President-elect Joe Biden's administration. Market participant...
Market Update: Stocks Fall as Investors Prepare for Harsh Winter Stocks fell throughout Friday's session as raising coronavirus cases reignited fear sentiment as more U.S. states and cities imposed social restrictions that threaten business ac...
Oxford, AstraZeneca Vaccine Produces Similar Immune Responses Across all Age Groups The coronavirus vaccine developed by the University of Oxford and the drugmaker AstraZeneca
Vaccine News Triggers Growth to Value Rotation In markets, investors are always accounting for the path vs the destination. For example, you may believe a stock is undervalued and should double to be appropriately valued. Tha...
Second Wave of Lockdowns Sweep United States It's starting to look a lot like March and April once again as a second wave of regional lockdown orders are enacted in various states and cities throughout the country. The fede...
Market Update: Stocks Fall in Afternoon Trading as NYC Schools Shift Back to Remote Learning Stocks fell Wednesday afternoon, reversing most of the gains made earlier after Pfizer